We are raising our full year outlook to reflect ongoing momentum in our underlying business as well as the addition of Naturium. For the full year, we now expect net sales growth of approximately 55% to 57%, up from 37% to 39% previously adjusted EBITDA between $197,000,000 to $200,000,000 up from $171,000,000 to $174,000,000 previously adjusted net income Between $144,000,000 to $146,000,000 up from $125,000,000 to $127,000,000 previously And adjusted EPS of $2.47 to $2.50 per diluted share, up from $2.19 to $2.22 previously. We continue to expect our fiscal 'twenty four adjusted tax rate to be approximately 17% to 18%. Lastly, we now expect a fully diluted average share count of approximately 58,000,000 shares, up from 57,000,000 shares previously. As a reminder, Naturium is expected to generate approximately $90,000,000 of net sales and $17,000,000 in adjusted EBITDA in the 12 months ending March 31, 2024.